GlaxoSmithKline Expands Its Use of InforSense Limited Platform

LONDON and CAMBRIDGE, MA--(Marketwire - July 25, 2008) - InforSense Ltd., the leading provider of next generation business and scientific intelligence tools, today announced that GlaxoSmithKline (GSK) has signed an agreement to continue their use of the InforSense platform and collaboration with the company. The InforSense system is currently leveraged by approximately 800 users across the organization.